Zacks Investment Research
05 Jun 2026, 22:46 UTC · 2h ago
CVS Health (CVS) Advances While Market Declines: Some Information for Investors
Zacks Investment Research
05 Jun 2026, 22:46 UTC · 2h ago
Story key points
3 claims · impact-rated
CVS Health has a Zacks Rank of #2 (Buy), with the Zacks Consensus EPS estimate increasing by 4.1% over the last 30 days. — Upward revisions in earnings estimates and a positive analyst rank typically signal bullish short-term price momentum.
+0.40CVS Health is trading at a Forward P/E of 12.75 and a PEG ratio of 0.93, representing a discount relative to its industry's Forward P/E of 15.35. — Undervaluation relative to peers and growth (PEG < 1) generally increases investor appetite for the stock.
+0.30CVS Health's full-year earnings and revenue are projected to grow by 10.22% and 1.72% respectively compared to last year. — Projected annual growth in bottom and top lines supports a positive long-term outlook for the company.
+0.20Ticker attribution
Model heads
Continue reading
6 related stories
Top 1 mover · tap to explore
The company outperformed the broader market, has a Zacks Rank of #2 (Buy), and shows positive upward revisions in EPS estimates.
Mentioned as a top-viewed stock on the platform, indicating high investor interest.
Mentioned as having significant page view growth.
Mentioned as a top-viewed stock on the platform, indicating high investor interest.
Mentioned as both a top-viewed stock and experiencing high page view growth.
Mentioned as a top-viewed stock on the platform, indicating high investor interest.
Mentioned as having significant page view growth.
Mentioned as a top-viewed stock on the platform, indicating high investor interest.
Mentioned as having significant page view growth.
Mentioned as having significant page view growth.
Mentioned as a top-viewed stock on the platform, indicating high investor interest.
Mentioned as having significant page view growth.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
2 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Zacks Investment Research
2h ago
